This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Hematology Diagnostics Market

Market Insights on Hematology Diagnostics covering sales outlook, demand forecast & up-to-date key trends

Hematology Diagnostics Market By Kit Type (Anemia & Iron Test Kits, Folic Acid Testing Kits, Sickle Cell Screening Kits, PT/INR Testing Kits, D-dimer Testing Kits, Blood Typing Kits, Leukemia Testing Kits, Sepsis Testing Kits, Antibiotic Resistance Panels, Bacterial & Fungal Panels), Modality (Point of Care, Lab-based Testing) & Region - Forecast 2022 - 2031

Hematology Diagnostics Market Outlook (2022-2031)

[228 Pages Report] Standing at a valuation of US$ 725 Mn in 2022, the global hematology diagnostics market is projected to reach US$ 1.2 Bn by the end of 2031. Demand for hematology diagnostics is anticipated to increase at a CAGR of 5.8%\ from 2022 to 2031.

Hematology Diagnostics Market Size (2022)

US$ 725 Mn

Global Market Revenue (2031)

US$ 1.2 Bn

Predicted Market Growth Rate (2022-2031)

5.8% CAGR

Increasing instances of blood disorders and blood cancer are expected to boost demand for diagnostic hematology over the coming years.

Customize this Report

Let us know your requirement to get
100% FREE customization

Demand Analysis of Hematology Diagnostics (2016 to 2021) Vs Projected Market Outlook (2022 to 2031)

Focus on diagnostics of multiple health conditions has bolstered over the past years and this trend is anticipated to be prominent over the forecast period as well. The market for hematology diagnostics rose at a CAGR of 4.2% CAGR from 2016 to 2021.

Rise in hematological testing, rising number of blood transfusions, growing prevalence of genetic diseases, rising geriatric population, rapid technological advancements, increasing adoption of automated hematology analyzers, and increasing instances of blood cancer are expected to majorly govern demand for hematology diagnostics through 2031.

Automation is also anticipated to be a major trend in the hematology diagnostics market owing to rising technological proliferation in the healthcare industry. The rising adoption of automated hematology analyzers is also predicted to see a hike as diagnostic labs and hospitals see an increase in healthcare automation.

Hematology diagnostic providers are anticipated to focus on developing advanced automated solutions owing to the increase in demand and adoption in the global market landscape.

Hematology Diagnostics Market Download Report Brochure

High costs of hematology diagnostics and lack of awareness about these diagnostics are anticipated to hinder hematology diagnostics market growth. The market for hematology diagnostics is anticipated to progress at a CAGR of 5.8% over the forecast period.

Which Market Factors are Driving Demand for Hematology Diagnostics?

“Rising Prevalence of Blood Disorders to Favor Diagnostic Hematology Demand”

The world has seen a substantial rise in instances of blood disorders and this subsequently increased the demand for hematology diagnostics. Blood cancer cases across the world have seen a sharp spike in recent years and this is majorly influencing hematology diagnostics market potential.

“Advancements in Blood Testing Diagnostics to Boost Market Potential”

As the prevalence of blood disorders increases so does the demand for better diagnostic solutions and this promotes hematology diagnostic providers to invest in the research and development of such solutions. Rising research and development activity is anticipated to result in diagnostic solutions with better efficacy and subsequently boost demand for hematology diagnostics through 2031.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What Could Hinder Hematology Diagnostics Market Growth?

“High Costs of Diagnostics Could Restrain Demand Growth”

Novel diagnostics procedures are costly and are on the expensive side of the spectrum which makes it difficult for people with low income to attain. High costs of hematology diagnostic procedures are a major restraining factor for the global hematology diagnostics market.

Other factors such as lack of awareness and coverage exclusion from healthcare insurance are also anticipated to negatively impact the hematology diagnostics market.

Which Regions Should Hematology Diagnostic Providers Keep a Close Eye On?

Hematology diagnostics market analysis for regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA) has been profiled in this study.

The North America hematology diagnostics market is anticipated to hold a dominant outlook through 2031 and emerge as a highly lucrative region for hematology diagnostics providers. The rising prevalence of blood cancer and the presence of key hematology diagnostics companies are expected to be major factors propelling growth in this region.

The market for hematology diagnostics in Europe is predicted to account for a significant market share over the forecast period. Growth in this region can be attributed to rising hematology research and supportive government initiatives to boost awareness for hematology diagnostics.

East Asia and South Asia are expected to provide a lucrative setting for hematology diagnostics market growth over the forecast period. The increasing prevalence of blood disorders, rising focus on healthcare, increasing healthcare spending, and rising instances of genetic blood disorders are expected to be major drivers for the hematology diagnostics market in East Asia and South Asia.

Demand is predicted to be majorly spearheaded by emerging economies such as India and China where medical tourism is flourishing.

The hematology diagnostics market in the MEA region holds a low market share but is anticipated to see substantial growth by the end of the forecast period. Rising investments in healthcare infrastructure and supportive government initiatives are anticipated to promote hematology diagnostics market potential in this region.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Analysis

How is the Hematology Diagnostics Market Expected to Perform in the U.S.?

“Rising Incidence of Blood Cancer to Boost Hematology Diagnostics Demand”

The U.S. has seen a spike in the incidence of blood cancer in recent years and is expected to see an increase over the forecast period as well. The U.S. market for hematology diagnostics is expected to provide highly lucrative opportunities due to high technological proliferation, the presence of developed healthcare infrastructure, and high research and development activity.

Will India Be a Lucrative Market for Hematology Diagnostic Companies?

“Increasing Focus on Healthcare to Positively Impact Hematology Diagnostics Market Potential”

Focus on healthcare has bolstered in recent years in India and this has created many opportunities for healthcare diagnostic providers. The nation is also experiencing a surge in instances of blood disorders and incidence of blood cancer which is also a factor that promotes demand for hematology diagnostics.

Hematology diagnostic providers can focus on India and gain from the untapped potential that the market has to offer and increase their global revenue potential.

Category-wise Analysis

Which Distribution Channel is Expected to Be Most Lucrative?

“Hospitals to Hold Dominant Outlook throughout Forecast Period”

Currently, the hospitals segment holds a dominant market share and is predicted to maintain this stance through 2031. However, the diagnostic laboratories segment is expected to experience rapid growth over the forecast period owing to an increasing number of diagnostic centers and increasing availability of advanced diagnostic instruments and devices.

COVID-19 Crisis Survey

In 2020, the world was plagued with coronavirus infections that led to a pandemic situation across the world. This unprecedented phenomenon took the markets by shock and had an adverse impact on the world economy.

The hematology diagnostics market also toppled amidst the lockdown restrictions that were imposed by multiple countries to contain the spread of coronavirus infections. However, demand for hematology diagnostics is expected to see a steady rise in the post-pandemic era and offer hematology diagnostic providers a chance to make a complete recovery from losses in 2020.

Competitive Landscape

Hematology diagnostic providers are investing in the research & development of novel diagnostic solutions to enhance their market presence and boost revenue generation potential.

Hematology diagnostic companies are also focusing on establishing new diagnostic centres to deploy novel diagnostic solutions.

  • In October 2021, Suburban Diagnostics, a leading name in the medical diagnostics industry, announced the launch of the Centre of Excellence in Hematology. The new establishment provides research support and training of diagnostic procedures for multiple common and uncommon hematological disorders.

Hematology Diagnostics Industry Report Scope

Attribute

Details

Forecast Period

2022-2031

Historical Data Available for

2016-2021

Market Analysis

US$ Mn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Turkey
  • South Africa
  • and GCC Countries

Key Market Segments Covered

  • Kit Type
  • Modality
  • Distribution Channel
  • Region

Key Companies Profiled

  • Meyland Smith A/S
  • Abbot Laboratories
  • Bio-Rad Laboratories
  • Sysmex Corporation
  • Mindray Medical International Limited
  • Siemens Healthlineers
  • F. Hoffman-La Roche Ltd.
  • HORIBA Ltd.
  • HemoCue AB
  • Danaher (Beckman Coulter Inc.)
  • Nihon Kohden Corporation
  • EKF Diagnostics
  • Ortho Clinical Diagnostics
  • Drew Scientific

Pricing

Available upon Request

Key Segments of Hematology Diagnostics Industry Survey

Hematology Diagnostics Market by Kit Type:

  • Anemia and Iron Test Kits
  • Folic Acid Testing Kits
  • Sickle Cell Screening Kits
  • PT/INR Testing Kits
  • D-dimer Testing Kits
  • Blood Typing Kits
  • Leukemia Testing Kits
  • Sepsis Testing Kits
  • Antibiotic Resistance Panels
  • Bacterial & Fungal Panels

Hematology Diagnostics Market by Modality:

  • Point of Care Hematology Diagnostics
  • Lab-based Testing Hematology Diagnostics

Hematology Diagnostics Market by Distribution Channel:

  • Hematology Diagnostics for Hospitals
  • Hematology Diagnostics for Diagnostic Laboratories
  • Hematology Diagnostics for Cancer Research Institutes
  • Hematology Diagnostics for Retail Pharmacies
  • Hematology Diagnostics for Drug Stores
  • Hematology Diagnostics for Online Sales Channels

Hematology Diagnostics Market by Region:

  • North America Hematology Diagnostics Market
  • Latin America Hematology Diagnostics Market
  • Europe Hematology Diagnostics Market
  • East Asia Hematology Diagnostics Market
  • South Asia & Pacific Hematology Diagnostics Market
  • Middle East & Africa (MEA) Hematology Diagnostics Market

Frequently Asked Questions

In 2022, the global hematology diagnostics market is valued at US$ 725 Mn.

The hospitals segment holds a dominant outlook in the global hematology diagnostics landscape.

As per these hematology diagnostics market insights, the industry is predicted to progress at a CAGR of 5.8% from 2022 to 2031.

By 2031, the hematology diagnostics market is predicted to rake in sales revenue worth US$ 1.2 Bn.

Prime market players such as Siemens Healthlineers, F. Hoffman-La Roche Ltd., HORIBA Ltd., HemoCue AB, Danaher (Beckman Coulter Inc.), Nihon Kohden Corporation, EKF Diagnostics, Ortho Clinical Diagnostics, and Drew Scientific are profiled in this hematology diagnostics market survey.

Table of Content

Section 01 Preface 

1.1 Report Scope and Market Segmentation 

1.2 Research Highlights

Section 02 Assumptions and Research Methodology 

2.1 Assumptions

2.2 Research Methodology

Section 03 Executive Summary

3.1 Global Hematology Diagnostics Market Size (US$ Mn) and Distribution by Geography, 2016 - 2021

3.2 Global Hematology Diagnostics Market Snapshot, 2016

3.3 Global Hematology Diagnostics Market: Opportunity Map

Section 04 Market Overview

4.1 Overview

4.2 Global Hematology Diagnostics Market Size (US$ Mn) Forecast, 2016 - 2021

4.3 Global Hematology Diagnostics Market Outlook

4.4 Global Hematology Diagnostics Market: Porter’s Five Forces Analysis

4.5 Hematology Analyzers Installed Base

4.6 Key Success factor for Top 3 Players

4.7 Technological Advancements

4.8 Disease Prevalence & Incidence Rate Globally with Key Countries

Section 05 Market Dynamics

5.1 Drivers

5.2 Restraints

5.3 Opportunity Analysis

5.4 Opportunities

5.5 Trends

Section 06 Hematology Diagnostics Market Analysis, by Product Type

6.1 Introduction

6.2 Global Hematology Diagnostics Market Value Share Analysis, by Product Type

6.3 Hematology Diagnostics Market Analysis, by Product Type 

      6.3.1 Hematology Instruments

              6.3.1.1 Hematology Analyzers

                        6.3.1.1.1 Fully-automated Hematology Analyzers

                        6.3.1.1.2 Semi-automated Hematology Analyzers 

              6.3.1.2 Flow Cytometers

              6.3.1.3 Others

      6.3.2 Hematology Consumables

              6.3.2.1 Reagents

              6.3.2.2 Stains

              6.3.2.3 Controls & Calibrators

              6.3.2.4 Others

6.4 Hematology Diagnostics Market Attractiveness Analysis, by Product Type 

6.5 Hematology Diagnostics Market Attractiveness Analysis, by Hematology Analyzers

6.6 Hematology Diagnostics Market Attractiveness Analysis, by Hematology Consumables

Section 07 Hematology Diagnostics Market Analysis, by End-user

7.1 Introduction

7.2 Global Hematology Diagnostics Market Value Share Analysis, by End-user

7.3 Hematology Diagnostics Market Analysis, by End-user

      7.3.1 Diagnostic Laboratories

      7.3.2 Hospitals & Clinics

      7.3.3 Academic Institutes

      7.3.4 Others

7.4 Hematology Diagnostics Market Attractiveness Analysis, by End-user

Section 08 Hematology Diagnostics Market Analysis, by Region

8.1 Global Hematology Diagnostics Market Snapshot, by Country

8.2 Global Hematology Diagnostics Market Value Share Analysis, by Region

8.3 Hematology Diagnostics Market Forecast, by Region

      8.3.1 North America

      8.3.2 Europe

      8.3.3 Asia Pacific

      8.3.4 Latin America

      8.3.5 Middle East & Africa

8.4 Hematology Diagnostics Market Attractiveness Analysis, by Region

8.5 Hematology Diagnostics Market: Regional Trends

Section 09 North America Hematology Diagnostics Market Analysis

9.1 Key Findings

9.2 North America Hematology Diagnostics Market Overview

9.3 North America Market Value Share Analysis, by Product Type

9.4 North America Market Forecast, by Product Type

      9.4.1 Hematology Instruments

      9.4.2 Hematology Consumables

9.5 North America Market Value Share Analysis, by Hematology Instruments

9.6 North America Market Forecast, by Hematology Instruments

      9.6.1 Hematology Analyzers

      9.6.2 Flow Cytometers

      9.6.3 Others

9.7 North America Market Value Share Analysis, by Hematology Consumables

9.8 North America Market Forecast, by Hematology Consumables

      9.8.1 Reagents

      9.8.2 Stains

      9.8.3 Controls & Calibrators

      9.8.4 Others

9.9 North America Market Value Share Analysis, by End-user

9.10 North America Market Forecast, by End-user

      9.10.1 Diagnostic Laboratories

      9.10.2 Hospitals & Clinics

      9.10.3 Academic Institutes

      9.10.4 Others

9.11 Market Analysis, by Country

9.12 Market Value Share Analysis, by Country

9.13 Market Size (US$ Mn) Forecast, by Country, 2022-2031

      9.13.1 U.S.

      9.13.2 Canada

9.14 Market Attractiveness Analysis

      9.14.1 by Product Type

      9.14.2 by Hematology Instruments

      9.14.3 by Hematology Consumables

      9.14.4 by End-user

      9.14.5 by Country

Section 10 Europe Hematology Diagnostics Market Analysis

10.1 Key Findings

10.2 Europe Hematology Diagnostics Market Overview

10.3 Europe Market Value Share Analysis, by Product Type

10.4 Europe Market Forecast, by Product Type

      10.4.1 Hematology Instruments

      10.4.2 Hematology Consumables

10.5 Europe Market Value Share Analysis, by Hematology Instruments

10.6 Europe Market Forecast, by Hematology Instruments

      10.6.1 Hematology Analyzers

      10.6.2 Flow Cytometers

      10.6.3 Others

10.7 Europe Market Value Share Analysis, by Hematology Consumables

10.8 Europe Market Forecast, by Hematology Consumables

      10.8.1 Reagents

      10.8.2 Stains

      10.8.3 Controls & Calibrators

      10.8.4 Others

10.9 Europe Market Value Share Analysis, by End-user

10.10 Europe Market Forecast, by End-user

      10.10.1 Diagnostic Laboratories

      10.10.2 Hospitals & Clinics

      10.10.3 Academic Institutes

      10.10.4 Others

10.11 Market Analysis, by Country

10.12 Market Value Share Analysis, by Country

10.13 Market Size (US$ Mn) Forecast, by Country, 2022-2031

      10.13.1 Germany

      10.13.2 France

      10.13.3 U.K.

      10.13.4 Italy

      10.13.5 Spain

      10.13.6 Rest of Europe

10.14 Market Attractiveness Analysis

      10.14.1 by Product Type

      10.14.2 by Hematology Instruments

      10.14.3 by Hematology Consumables

      10.14.4 by End-user

      10.14.5 by Country

Section 11 Asia Pacific Hematology Diagnostics Market Analysis

11.1 Key Findings

11.2 Asia Pacific Hematology Diagnostics Market Overview

11.3 Asia Pacific Market Value Share Analysis, by Product Type

11.4 Asia Pacific Market Forecast, by Product Type

      11.4.1 Hematology Instruments

      11.4.2 Hematology Consumables

11.5 Asia Pacific Market Value Share Analysis, by Hematology Instruments

11.6 Asia Pacific Market Forecast, by Hematology Instruments

      11.6.1 Hematology Analyzers

      11.6.2 Flow Cytometers

      11.6.3 Others

11.7 Asia Pacific Market Value Share Analysis, by Hematology Consumables

11.8 Asia Pacific Market Forecast, by Hematology Consumables

      11.8.1 Reagents

      11.8.2 Stains

      11.8.3 Controls & Calibrators

      11.8.4 Others

11.9 Asia Pacific Market Value Share Analysis, by End-user

11.10 Asia Pacific Market Forecast, by End-user

      11.10.1 Diagnostic Laboratories

      11.10.2 Hospitals & Clinics

      11.10.3 Academic Institutes

      11.10.4 Others

11.11 Market Analysis, by Country

11.12 Market Value Share Analysis, by Country

11.13 Market Size (US$ Mn) Forecast, by Country, 2022-2031

      11.13.1 China

      11.13.2 Japan

      11.13.3 India

      11.13.4 Australia & New Zealand

      11.13.5 Rest of Asia Pacific

11.14 Market Attractiveness Analysis

      11.14.1 by Product Type

      11.14.2 by Hematology Instruments

      11.14.3 by Hematology Consumables

      11.14.4 by End-user

      11.14.5 by Country

Section 12 Latin America Hematology Diagnostics Market Analysis

12.1 Key Findings

12.2 Latin America Hematology Diagnostics Market Overview

12.3 Latin America Market Value Share Analysis, by Product Type

12.4 Latin America Market Forecast, by Product Type

      12.4.1 Hematology Instruments

      12.4.2 Hematology Consumables

12.5 Latin America Market Value Share Analysis, by Hematology Instruments

12.6 Latin America Market Forecast, by Hematology Instruments

      12.6.1 Hematology Analyzers

      12.6.2 Flow Cytometers

      12.6.3 Others

12.7 Latin America Market Value Share Analysis, by Hematology Consumables

12.8 Latin America Market Forecast, by Hematology Consumables

      12.8.1 Reagents

      12.8.2 Stains

      12.8.3 Controls & Calibrators

      12.8.4 Others

12.9 Latin America Market Value Share Analysis, by End-user

12.10 Latin America Market Forecast, by End-user

      12.10.1 Diagnostic Laboratories

      12.10.2 Hospitals & Clinics

      12.10.3 Academic Institutes

      12.10.4 Others

12.11 Market Analysis, by Country

12.12 Market Value Share Analysis, by Country

12.13 Market Size (US$ Mn) Forecast, by Country, 2022-2031

      12.13.1 Brazil

      12.13.2 Mexico

      12.13.3 Rest of Latin America

12.14 Market Attractiveness Analysis

      12.14.1 by Product Type

      12.14.2 by Hematology Instruments

      12.14.3 by Hematology Consumables

      12.14.4 by End-user

      12.14.5 by Country

Section 13 Middle East & Africa Hematology Diagnostics Market Analysis

13.1 Key Findings

13.2 Middle East & Africa Hematology Diagnostics Market Overview

13.3 Middle East & Africa Market Value Share Analysis, by Product Type

13.4 Middle East & Africa Market Forecast, by Product Type

      13.4.1 Hematology Instruments

      13.4.2 Hematology Consumables

13.5 Middle East & Africa Market Value Share Analysis, by Hematology Instruments

13.6 Middle East & Africa Market Forecast, by Hematology Instruments

      13.6.1 Hematology Analyzers

      13.6.2 Flow Cytometers

      13.6.3 Others

13.7 Middle East & Africa Market Value Share Analysis, by Hematology Consumables

13.8 Middle East & Africa Market Forecast, by Hematology Consumables

      13.8.1 Reagents

      13.8.2 Stains

      13.8.3 Controls & Calibrators

      13.8.4 Others

13.9 Middle East & Africa Market Value Share Analysis, by End-user

13.10 Middle East & Africa Market Forecast, by End-user

      13.10.1 Diagnostic Laboratories

      13.10.2 Hospitals & Clinics

      13.10.3 Academic Institutes

      13.10.4 Others

13.11 Market Analysis, by Country

13.12 Market Value Share Analysis, by Country

13.13 Market Size (US$ Mn) Forecast, by Country, 2022-2031

      13.13.1 GCC Countries

      13.13.2 South Africa

      13.13.3 Rest of Middle East & Africa

13.14 Market Attractiveness Analysis

      13.14.1 By Product Type

      13.14.2 by Hematology Instruments

      13.14.3 by Hematology Consumables

      13.14.4 by End-user

      13.14.5 by Country

Section 14 Competition Landscape

14.1 Competition Matrix

14.2 Hematology Diagnostics Market Share Analysis, by Company (2016)

14.3 Company Profiles

      14.3.1 Abbott Laboratories

             14.3.1.1 Company Description

             14.3.1.2 Financial Overview

             14.3.1.3 Strategy & Recent Developments

             14.3.1.4 SWOT Analysis

      14.3.2 Bio-Rad Laboratories, Inc.

             14.3.2.1 Company Description

             14.3.2.2 Financial Overview

             14.3.2.3 Strategy & Recent Developments

             14.3.2.4 SWOT Analysis

      14.3.3 Sysmex Corporation

             14.3.3.1 Company Description

             14.3.3.2 Financial Overview

             14.3.3.3 Strategy & Recent Developments

             14.3.3.4 SWOT Analysis

     14.3.4 Mindray Medical International Limited

             14.3.4.1 Company Description

             14.3.4.2 Financial Overview

             14.3.4.3 Strategy & Recent Developments

             14.3.4.4 SWOT Analysis

     14.3.5 Siemens Healthineers

             14.3.5.1 Company Description

             14.3.5.2 Financial Overview

             14.3.5.3 Strategy & Recent Developments

             14.3.5.4 SWOT Analysis

      14.3.6 F. Hoffmann-La Roche Ltd. 

             14.3.6.1 Company Description

             14.3.6.2 Financial Overview

             14.3.6.3 Strategy & Recent Developments

             14.3.6.4 SWOT Analysis

     14.3.7 HORIBA, Ltd. 

             14.3.7.1 Company Description

             14.3.7.2 Financial Overview

             14.3.7.3 Strategy & Recent Developments

             14.3.7.4 SWOT Analysis

     14.3.8 HemoCue AB

             14.3.8.1 Company Description

             14.3.8.2 Financial Overview

             14.3.8.3 Strategy & Recent Developments

             14.3.8.4 SWOT Analysis

     14.3.9 Danaher (Beckman Coulter, Inc.)

             14.3.9.1 Company Description

             14.3.9.2 Financial Overview

             14.3.9.3 Strategy & Recent Developments

             14.3.9.4 SWOT Analysis

     14.3.10 Nihon Kohden Corporation

             14.3.10.1 Company Description

             14.3.10.2 Financial Overview

             14.3.10.3 Strategy & Recent Developments

             14.3.10.4 SWOT Analysis

     14.3.11 EKF Diagnostics

             14.3.11.1 Company Description

             14.3.11.2 Financial Overview

             14.3.11.3 Strategy & Recent Developments

             14.3.11.4 SWOT Analysis

     14.3.12 Ortho Clinical Diagnostics

             14.3.12.1 Company Description

             14.3.12.2 Financial Overview

             14.3.12.3 Strategy & Recent Developments

             14.3.12.4 SWOT Analysis

     14.3.13 Drew Scientific

             14.3.13.1 Company Description

             14.3.13.2 Financial Overview

             14.3.13.3 Strategy & Recent Developments

             14.3.13.4 SWOT Analysis

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Hematology diagnostics Market Analysis, by Installed Base

Table 02: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2031

Table 03: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2031

Table 04: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2031

Table 05: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2031

Table 06: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2031

Table 07: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Region, 2016–2031

Table 08: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2031

Table 09: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2031

Table 10: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2031

Table 11: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2031

Table 12: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2031

Table 13: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2031

Table 14: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2031

Table 15: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2031

Table 16: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2031

Table 17: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2031

Table 18: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2031

Table 19: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2031

Table 20: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2031

Table 21: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2031

Table 22: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2031

Table 23: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2031

Table 24: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2031

Table 25: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2031

Table 26: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2031

Table 27: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2031

Table 28: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2031

Table 29: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2031

Table 30: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2031

Table 31: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2031

Table 32: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2031

Table 33: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2031

Table 34: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2031

Table 35: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2031

Table 36: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2031

Table 37: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2031

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 01: Global Hematology Diagnostics Market Size (US$ Mn) and Distribution, by Region, 2016-2021

Figure 02: Global Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 03: Hematology Diagnostics Market Value Share, by Product Type, 2016

Figure 04: Hematology Diagnostics Market Value Share, by Hematology Consumables, 2016

Figure 05: Hematology Diagnostics Market Value Share, by Hematology Instruments, 2016

Figure 06: Hematology Diagnostics Market Value Share, by Region, 2016

Figure 07: Expected New Cases of Leukemia, Lymphoma, or Myeloma in 2016

Figure 08: Global Hematology Diagnostics Market Value Share, by Product Type, 2016-2021

Figure 09: Global Hematology Diagnostics Market Value Share, by Hematology Instruments, 2016-2021

Figure 10: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hematology Analyzers, 2016–2026

Figure 11: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Flow Cytometers, 2016–2026

Figure 12: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026

Figure 13: Global Hematology Diagnostics Market Value Share, by Hematology Consumables, 2016-2021

Figure 14: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reagents, 2016–2026

Figure 15: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stains, 2016–2026

Figure 16: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Controls & Calibrators, 2016–2026

Figure 17: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026

Figure 19: Global Hematology Diagnostics Market Attractiveness Analysis, by Hematology Instruments, 2022-2031

Figure 18: Global Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022-2031

Figure 20: Global Hematology Diagnostics Market Attractiveness Analysis, by Hematology Consumables, 2022-2031

Figure 21: Global Hematology Diagnostics Market Value Share, by End-user, 2016-2021

Figure 22: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2016–2026

Figure 23: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals & Clinics, 2016–2026

Figure 24: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic Institutes, 2016–2026

Figure 25: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026

Figure 26: Global Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031

Figure 27: Global Hematology Diagnostics Market Value Share, by Region, 2016-2021

Figure 28: Global Hematology Diagnostics Market Attractiveness Analysis, by Region, 2022-2031

Figure 29: North America Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 30: North America Hematology Diagnostics Market Value Share, by Country, 2016-2021

Figure 31: North America Hematology Diagnostics Market Attractiveness, by Country, 2022-2031

Figure 32: North America Hematology Diagnostics Market Value Share, by Product Type, 2016-2021

Figure 33: North America Hematology Diagnostics Market Attractiveness, by Product Type, 2022-2031

Figure 34: North America Hematology Diagnostics Market Value Share, by Hematology Instruments, 2016-2021

Figure 35: North America Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2022-2031

Figure 36: North America Hematology Diagnostics Market Value Share, by Hematology Consumables, 2016-2021

Figure 37: North America Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2022-2031

Figure 38: North America Hematology Diagnostics Market Value Share, by End-user, 2016-2021

Figure 39: North America Hematology Diagnostics Market Attractiveness, by End-user, 2022-2031

Figure 40: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 41: Europe Hematology Diagnostics Market Value Share, by Country/Sub-region, 2016-2021

Figure 42: Europe Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2022-2031

Figure 43: Europe Hematology Diagnostics Market Value Share, by Product Type, 2016-2021

Figure 44: Europe Hematology Diagnostics Market Attractiveness, by Product Type, 2022-2031

Figure 45: Europe Hematology Diagnostics Market Value Share, by Hematology Instruments, 2016-2021

Figure 46: Europe Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2022-2031

Figure 47: Europe Hematology Diagnostics Market Value Share, by Hematology Consumables, 2016-2021

Figure 48: Europe Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2022-2031

Figure 49: Europe Hematology Diagnostics Market Value Share, by End-user, 2016-2021

Figure 50: Europe Hematology Diagnostics Market Attractiveness, by End-user, 2022-2031

Figure 51: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 52: Asia Pacific Hematology Diagnostics Market Value Share, by Country/Sub-region, 2016-2021

Figure 53: Asia Pacific Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2022-2031

Figure 54: Asia Pacific Hematology Diagnostics Market Value Share, by Product Type, 2016-2021

Figure 55: Asia Pacific Hematology Diagnostics Market Attractiveness, by Product Type, 2022-2031

Figure 56: Asia Pacific Hematology Diagnostics Market Value Share, by Hematology Instruments, 2016-2021

Figure 57: Asia Pacific Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2022-2031

Figure 58: Asia Pacific Hematology Diagnostics Market Value Share, by Hematology Consumables, 2016-2021

Figure 59: Asia Pacific Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2022-2031

Figure 60: Asia Pacific Hematology Diagnostics Market Value Share, by End-user, 2016-2021

Figure 61: Europe Hematology Diagnostics Market Attractiveness, by End-user, 2022-2031

Figure 62: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 63: Latin America Hematology Diagnostics Market Value Share, by Country/Sub-region, 2016-2021

Figure 64: Latin America Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2022-2031

Figure 65: Latin America Hematology Diagnostics Market Value Share, by Product Type, 2016-2021

Figure 66: Latin America Hematology Diagnostics Market Attractiveness, by Product Type, 2022-2031

Figure 67: Latin America Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2022-2031

Figure 68: Latin America Hematology Diagnostics Market Value Share, by Hematology Instruments, 2016-2021

Figure 69: Latin America Hematology Diagnostics Market Value Share, by Hematology Consumables, 2016-2021

Figure 70: Latin America Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2022-2031

Figure 71: Latin America Hematology Diagnostics Market Value Share, by End-user, 2016-2021

Figure 72: Latin America Hematology Diagnostics Market Attractiveness, by End-user, 2022-2031

Figure 73: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 74: Middle East & Africa Hematology Diagnostics Market Value Share, by Country/Sub-region, 2016-2021

Figure 75: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2022-2031

Figure 76: Middle East & Africa Hematology Diagnostics Market Value Share, by Product Type, 2016-2021

Figure 77: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Product Type, 2022-2031

Figure 78: Middle East & Africa Hematology Diagnostics Market Value Share, by Hematology Instruments, 2016-2021

Figure 79: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2022-2031

Figure 80: Middle East & Africa Hematology Diagnostics Market Value Share, by Hematology Consumables, 2016-2021

Figure 81: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2022-2031

Figure 82: Middle East & Africa Hematology Diagnostics Market Value Share, by End-user, 2016-2021

Figure 83: Middle East & Africa Hematology Diagnostics Market Attractiveness, by End-user, 2022-2031

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Poultry Diagnostics Market

Published : November 2020

Healthcare

Molecular Diagnostics Market

Published : February 2016

Healthcare

Companion Diagnostics Market

Published : February 2016

Healthcare

Tissue Diagnostics Market

Published : July 2020

Google translate

Hematology Diagnostics Market